Qualigen Therapeutics, Inc.
USD3.21
+0.17 (+5.59%)
CEO
Kevin A. Richardson II
IPO Date
2015-06-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.98
Prev. Close
$3.04
Day Low
$2.86
Day High
$3.34
52W Low
$1.61
52W High
$8.81
Market Cap
$0.01B
Volume
0.37M
| -0.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 637.8% | -659.9% | -0.62 | 0.28 | -0.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -257.6% | -97.7% | 0.24 | 1.26 | -0.3 |
| 31 Dec 2021 | FY | 23.4% | -316.6% | -108.0% | -78.4% | 0.10 | 4.49 | -1.8 |
| 31 Dec 2020 | FY | -66.9% | -474.2% | -111.6% | -70.1% | 0.03 | 2.71 | -2.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -921.2% | -362.3% | 0.09 | 1.30 | -0.2 |
| 31 Mar 2019 | FY | 6.5% | -20.7% | 810.4% | -30.3% | -13.73 | 0.50 | -110.0 |
| 31 Mar 2018 | FY | 17.0% | -3.6% | -35.0% | -8.5% | 0.70 | 0.68 | -1010.7 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -448.1% | -254.0% | 0.00 | 2.30 | -1.3 |
| -0.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -5.3% | -4.7% | 0.08 | 8.83 | -0.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 102.0% | -42.5% | -2.19 | 0.71 | -0.9 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -7986.3% | -92.9% | 25.46 | 1.01 | -0.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -31.9% | -18.3% | 0.00 | 2.33 | -1.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 83.8% | -77.6% | -0.67 | 0.52 | -0.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 36.9% | -295.0% | -0.39 | 0.11 | -0.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 57.7% | -202.6% | -0.29 | 0.22 | -0.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 116.5% | -120.5% | -0.62 | 0.28 | -0.3 |